Hurley Ariel

Avg. Two Year Performance

No purchase track record
(< 1%) Avg. Sale Return
0% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(3%)2%3%3%(< 1%)
Sale Success Rate4 of 197 of 199 of 195 of 190 of 19

Blueprint Medicines Corp

Drugs » Biotechnology

Principal Accounting Officer:

Holdings: 14.91K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--